|2022 Deadlines TBD||Conquer Cancer Foundation of the ASCO||$50,000/ |
|The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment. The Young Investigator Award is a one-year grant totaling $50,000 to pay for personnel and/or research expenses, and travel to attend the Conquer Cancer Grants and Awards Ceremony at the ASCO Annual Meeting. The number of YIA grants in each funding cycle is not predetermined by the Conquer Cancer Foundation. Awards are given based on individual merit and availability of funds. |
Information regarding 2022 YIA competitions will be posted in June.
|Clinical research||Prior Grant Cycle Eligibility (Will be updated when new RFP is released) |
Be a physician (MD, DO, or international equivalent) working in any country and currently in the last two years of his/her final subspecialty training at an academic medical institution and within 10 years of obtaining his/her medical degree at the time of grant submission. Examples of subspecialty training include, but are not limited to, a hematology-oncology fellowship, a surgical oncology fellowship, or a radiation oncology residency. An MD, PhD is eligible if both degrees are completed prior to the start of the grant period.
Be planning an investigative career in clinical oncology. Have a valid, active medical license in the country where the research will be conducted at the time of application. An institutional commitment for a faculty appointment at the time of grant submission is not required, but the applicant should be working in an oncology laboratory or clinical research setting.
Have a mentor in the proposed research field from the sponsoring institution. The mentor must assume responsibility and provide guidance for the research. If the mentor is not an ASCO member, a supporting letter from an ASCO member from the sponsoring institution must be included.
Be an ASCO member or have submitted a membership application with the grant application. To apply for new membership, or to renew an existing membership, go to www.asco.org/membership.
Be able to commit at least 60% of full- time effort in research (applies to total research, not just the proposed project) during the award period.
Eligible physicians are allowed to hold only one grant from the Conquer Cancer Foundation at a time.
|Rolling||EMBO European Molecular Biology Organization||Varies||EMBO Post-Doctoral Fellowships support excellent postdoctoral researchers throughout Europe and the world for a period of up to two years. International mobility is a key requirement. The fellowship includes a salary or stipend, a relocation allowance and support for fellows with children. Awardees can attend an EMBO Laboratory Leadership course and become part of the global network of EMBO Fellows. |
The European Molecular Biology Conference (EMBC), is an inter-governmental organization comprising of 30 Member
States including most of the European Union and some of the neighboring countries, provides funding for EMBO to
execute the EMBC General Programme, including the EMBO Fellowship Programme.
|Molecular Biology||Applicants must hold a PhD degree or equivalent at the start of the fellowship, but not necessarily at the time the application is complete. |
Applicants who already hold a PhD degree are eligible if they obtained their PhD degree during the two years prior to the date the application is complete.
Exceptions to this rule are made for applicants with career breaks during the relevant period due to parental leave and mandatory military civil service in which case the time of the career break will not be counted. Additional exceptions might be made on a case-by-case basis for extraordinary personal circumstances, such as demonstrable severe illness or full time care of an ill family member. No exceptions will be made for other types of voluntary career breaks.
The Fellowship Office can provide further information and must be contacted prior to submitting a claim for an exception, no matter what type.
Candidates with a medical degree (M.D.) may be eligible to apply for an EMBO Postdoctoral Fellowship provided they hold a PhD (MD-PhD programme), in which case, the rules explained above apply. If you do not have a PhD but have appropriate research experience that is comparable to a PhD and meet all other eligibility criteria, please contact the EMBO Fellowship office prior to submission
|2021 Deadline TBD |
Last Application Deadline:
|Alfred P. Sloan Foundation||$75,000 / |
|The Sloan Research Fellowships seek to stimulate fundamental research by early-career scientists and scholars of outstanding promise. These two-year, $75,000 fellowships are awarded yearly to 126 researchers in recognition of distinguished performance and a unique potential to make substantial contributions to their field.||General||Prior Grant Cycle Eligibility (Will be updated when new RFP is released) |
Candidates must hold a Ph.D. or equivalent degree in chemistry, computer science, Earth system science, economics, mathematics, neuroscience, physics, or a related field.
Candidates must be members of the faculty of a college, university, or other degree-granting institution in the U.S. or Canada.
Candidates must be tenure-track, though untenured, as of September 15 of the nomination year.
Candidate’s faculty position must carry a regular teaching obligation
|2021 Deadline: TBD |
Last LOI Deadline: 9/18/2020
Last Application Deadline:
|Hope Funds for Cancer Research||$158,500/ |
|Postdoctoral Fellowship - The Hope Funds for Cancer Research is offering fellowships to postdoctoral scientists who propose to work on highly innovative research projects that challenge the traditional paradigms of understanding the causes, mechanisms, progression, disease markers or risk factors of the most difficult-to-treat cancers, including pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, bone and ovarian cancers; and rare leukemias, lymphomas and MDS. The Trustees of the Hope Funds believe that funding research that could lead to breakthroughs in these areas and increase life expectancy in these types of cancers is at the core of its mission. The Fellowship Review Committee will consider each of the following criteria, with a strong emphasis on the innovation of the project, in evaluating candidates.||Pancreatic, lung, liver, sarcomas, esophageal, brain, gastric, bone and ovarian cancers; and rare leukemias, lymphomas and MDS||Prior Grant Cycle Eligibility (Will be updated when new RFP is released) |
Candidates must have completed one or more of the following degrees or its equivalent: MD, PhD, MD/PhD, DDS, DVM. For foreign-trained physicians, equivalency will be determined on a case-by-case basis.
Candidates must conduct their proposed research under a sponsor who holds a formal appointment at the host institution.
Candidates can apply prior to starting or during their postdoctoral appointments provided they have been formally accepted into the lab they are applying from, and current postdoctoral scientists must not have been in their Sponsor’s lab for more than two years as of September 18, 2020.
Candidates who have already accepted other postdoctoral research fellowship awards are not eligible.
The proposed investigation must be conducted at a university, hospital or research institution in the United States.
The Hope Funds for Cancer Research does not support research at for-profit institutions.
No Citizenship Req.
|2021 Deadline: (Announced Fall 2021) |
Last Application Deadline: 11/12/2019
|American Association for Cancer Research - Conquer Cancer Foundation of the ASCO||$50,000/ |
|The AACR-Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this jointly-supported award is to fund a physician-scientist during the transition from a fellowship program to a faculty appointment. Research projects are restricted to translational cancer research. |
The grant provides $50,000 over one year for expenses related to the research project, which may include salary and benefits of the grant recipient, other personnel, research/laboratory supplies, equipment, publication charges for manuscripts that pertain directly to the funded project, other research expenses, and indirect costs.
|Prior Grant Cycle Eligibility (Will be updated when new RFP is released) |
At the start of the grant term on July 1, 2020, applicants must be in the last two years of their final subspecialty training and within 10 years of obtaining their medical degree; have a valid, active medical license in the country where the research will be conducted; have a mentor in the proposed research field from the sponsoring institution that will assume responsibility and provide guidance for the research; be able to commit at least 60% of full-time effort in research (applies to total research, not just the proposed project) during the grant term; be planning an investigative career in clinical oncology; and work in an oncology laboratory or clinical research setting at an academic medical institution anywhere in the world.
Applicants must have a medical degree (MD, DO, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree.
Investigators may submit only one application for the AACR-Conquer Cancer Foundation of ASCO Young Investigator Award for Translational Cancer Research but may concurrently apply for other AACR grants. However, applicants are expected to accept the first grant they are awarded. Individuals may accept and hold only one AACR grant at a time.
Employees or subcontractors of a U.S. government entity or for-profit private industry are not eligible.
Any individual who currently holds an active AACR grant may not apply. Past grantees may apply if they complied with all progress and financial report requirements.
Previous or current recipients of a Conquer Cancer Foundation of ASCO Young Investigator Award or an AACR-Conquer Cancer Foundation of ASCO Young Investigator Award for Translational Cancer Research are not eligible.
|Application Deadline: |
|Damon Runyon Cancer Research Foundation||$460,000 |
Damon Runyon Physician-Scientist Training Award is a pilot program designed to recruit outstanding U.S. Specialty Board-eligible physicians into cancer research careers by providing them with the opportunity for a protected research training experience under the mentorship of a highly qualified and gifted mentor after they have completed all of their clinical training. The goals are to: a) transform these individuals into the highest quality physician-scientists, capable of conducting research that has the potential to transform the diagnosis, treatment and/or prevention of cancer; and b) to eliminate the financial disincentive to entering this career path.
|Postdoctoral||Physician-scientist applicants (MDs only) must have completed their residencies and clinical training, be U.S. Specialty Board eligible at the time of application, and be able to devote at least 80% of their time and effort to Damon Runyon-supported research. MD/PhDs are not eligible to apply, and applicants cannot be pursuing a PhD. |
The candidate may not have had more than three years of postdoctoral laboratory research experience.
Applicants may apply at any time prior to their initial assistant professorship appointment (or equivalent). Postdoctoral fellows, clinical fellows, and clinical instructors are eligible to apply. If the Awardee transitions to an assistant professorship appointment (or equivalent) during the award term, he/she must terminate the award.
Candidates holding or awarded NIH K awards at the time of application are not eligible to apply. (Candidates holding institutional K12 awards may apply, but must return their K12 funding to the US Government/NIH if they are awarded a Damon Runyon Physician-Scientist Training Award.)
Candidates must apply with a Mentor.
Only one application will be accepted from a Mentor per review session (including Co-Mentors); there is no limit, however, to the number of applications from an institution. No more than two Damon Runyon Physician-Scientists will be funded to work with the same Mentor at any given time (including Co-Mentors). Eligible candidates may apply up to two times.
|2021 Deadline TBD |
Last LOI Deadline: 12/14/2019
Last Application Deadline: 3/18/2020
|American Brain Tumor Association||$100,000/ |
|Basic Research Fellowship Grants are two year, $100,000 grants supporting postdoctoral fellows conducting laboratory or field-based research projects that focus on brain tumors. Fellows must have a lead mentor who currently conducts brain tumor research at the same academic institution. The mentor will help with scientific management and other research guidance to foster the applicant’s career advancement. Due to the COVID-19 pandemic, the ABTA is not able to accept applications for Basic Research Fellowships for the 2021 grant cycle. Projects are pre-screened by Letter of Intent (LOI), typically open in early November with LOIs due in December. Invitations and instructions to submit a complete proposal are extended by email in February, with applications due in March||Brain tumors||Prior Grant Cycle Eligibility (Will be updated when new RFP is released) |
Applicants must have their doctorate conferred no later than the Letter of Intent submission deadline (early December).
Applicants who are not yet at their mentor’s institution are eligible to apply provided that they will be starting their position at their mentor’s institution no later than the Full Application deadline (usually in March) and that they meet all other eligibility criteria. Please refer to the Request for Applications in the year that you are applying for more information.
Basic Research Fellowships allow for up to two mentors to be included in the application. One mentor must serve as the Lead Mentor, be at the same institution as the applicant and conduct brain tumor research. A single Co-Mentor is optional for all Basic Research Fellowship applicants. Each mentor must submit a Letter of Support and a biosketch as part of the Letter of Intent submission.
Applicants do not have to be U.S. citizens or residents and can be conducting research at a non-profit, non-governmental research institution anywhere in the world.
|2021 Deadline: TBD |
Last Application Deadline: 12/23/2020
|National Cancer Center||$82,000/ |
|National Cancer Center (NCC) has established funding for a limited number of post-doctoral fellowships for qualified applicants to receive training and experience in molecular genetics and the cellular aspects of cancer biology and tumor immunology. Preference will be given to studies that have direct relevance to the diagnosis and treatment of human cancer. Post-doctoral fellowships from NCC are established at $40,000 for the first year and $42,000. in the second year, if renewed. |
Fellowship awards are not necessarily restricted to salary. Depending on the
circumstances, part of the funds may be used for supplies or other valid expenses, which
should be listed in the proposed budget. NCC reserves the right to delete any item it
|Molecular genetics/ |
|Prior Grant Cycle Eligibility (Will be updated when new RFP is released) |
Fellowships are intended for applicants under age 35 with less than two years of post-doctoral laboratory experience, except in extenuating circumstances.
Fellowships are also limited to applicants having received no more than one prior fellowship or one career development award. Individuals receiving concurrent support from another organization are not eligible to apply.
Awards are limited to one per laboratory. There can be several different applications if they are on different topics. However, only one award could be made per lab in any round of applications.